Aisling Capital is a leading investment firm that invests in companies developing and commercializing important and innovative healthcare products, services and technologies.

Meet Our Team

A combined 150+ years of experience in the healthcare industry.

learn more

See Our Portfolio

$1.6 billion in assets, with a track record of investing and returning capital since 2000.

learn more

Latest News

EarLens Featured on ABC7 News: EarLens Hearing Aid Uses Laser Light to Transmit Sound

January 19, 2016
MENLO PARK, Calif. (KGO) -- If you enjoy all the live performances in the Bay Area, you are no doubt grateful for the gift of sound. One Bay Area company…

Loxo Oncology Announces EMA Orphan Drug Designation Granted to LOXO-101 for Treatment of Soft Tissue Sarcoma

January 15, 2016
STAMFORD, Conn., Jan. 15, 2016 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced…

Esperion Therapeutics Announces Initiation of Phase 3 Clinical Program With Long-Term Safety and Tolerability Study

January 13, 2016
— Company to Provide Details of Phase 3 Global Development Strategy in Q2 2016 — ANN ARBOR, Mich., Jan. 13, 2016 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), a pharmaceutical…